An Unused Curative Option in RCC?An Unused Curative Option in RCC?
Dr. Gert De Meerleer discusses the use of stereotactic body radiation therapy (SBRT) to control and potentially cure limited metastatic disease in renal cell carcinoma. Medscape Oncology
Source: Medscape Nephrology Headlines - Category: Urology & Nephrology Tags: Hematology-Oncology Expert Interview Source Type: news
More News: Cancer & Oncology | Carcinoma | Hematology | Kidney Cancer | Radiation Therapy | Renal Cell Carcinoma | Urology & Nephrology